Webcast link Play video

Chief Executive Officer, Lisa Anson discusses Redx’s pipeline progress

Chief Scientific Officer, Richard Armer provides a recap on lead fibrosis asset, RXC007 which has potential for development in multiple fibrotic conditions

Chief Medical Officer, Jane Robertson provides an update on progress of our lead cancer drug candidate RXC004

Interim 2021 Results webcast (07-June-2021)

Annual results presentation webcast (15-Feb-2021)

Cowen Health Care Conference Presentation (Thursday 04-March-2021 at 16:10 GMT / 11:10 EST)

CEO Lisa Anson discussed £25.5m raise to drive forward key programmes

Chief Medical Officer, Dr Andrew Saunders, provides updates on lead oncology asset RXC004

Chief Scientific Officer Richard Armer provides updates on lead fibrosis asset RXC007 which has potential for development in multiple fibrotic conditions